Report Detail
Transcatheter Aortic Valves Implantation (TAVI) - Medical Devices Pipeline Assessment, 2019
- RnM3864414 |
- 10 January, 2020 |
- Global |
- 197 Pages |
- GlobalData |
- Medical Devices & Consumables
Transcatheter Aortic Valves Implantation (TAVI) - Medical Devices Pipeline Assessment, 2019
Summary
GlobalData's Medical Devices sector report, “Transcatheter Aortic Valves Implantation (TAVI) - Medical Devices Pipeline Assessment, 2019" provides an overview of Transcatheter Aortic Valves Implantation (TAVI) currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transcatheter Aortic Valves Implantation (TAVI) pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Transcatheter Aortic Valves Implantation (TAVI) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Transcatheter Aortic Valves Implantation (TAVI) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Transcatheter Aortic Valves Implantation (TAVI) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
- 1.1 List of Tables 6
- 1.2 List of Figures 12
2 Introduction 13
- 2.1 Transcatheter Aortic Valve Implantation (TAVI) Overview 13
3 Products under Development 14
- 3.1 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development 14
- 3.2 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Territory 15
- 3.3 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Regulatory Path 16
- 3.4 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Estimated Approval Date 17
- 3.5 Transcatheter Aortic Valve Implantation (TAVI) - Ongoing Clinical Trials 18
4 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products under Development by Companies 19
- 4.1 Transcatheter Aortic Valve Implantation (TAVI) Companies - Pipeline Products by Stage of Development 19
- 4.2 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development 21
5 Transcatheter Aortic Valve Implantation (TAVI) Companies and Product Overview 23
- 5.1 Admedus Ltd Company Overview 23
- 5.1.1 Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
- 5.2 Aegis Surgical Limited Company Overview 25
- 5.2.1 Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview 25
- 5.3 AorTx, Inc. Company Overview 26
- 5.3.1 AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
- 5.4 Arbor Surgical Technologies, Inc. Company Overview 27
- 5.4.1 Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
- 5.5 Boston Scientific Corp Company Overview 28
- 5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 28
- 5.6 Carena Healthcare Ltd Company Overview 54
- 5.6.1 Carena Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 54
- 5.7 Clemson University Company Overview 55
- 5.7.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 55
- 5.8 Colibri Heart Valve LLC Company Overview 56
- 5.8.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview 56
- 5.9 Daidalos Solutions BV Company Overview 62
- 5.9.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 62
- 5.10 Direct Flow Medical Inc (Inactive) Company Overview 63
- 5.10.1 Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 63
- 5.11 DSM Dyneema BV Company Overview 67
- 5.11.1 DSM Dyneema BV Pipeline Products & Ongoing Clinical Trials Overview 67
- 5.12 Dura LLC Company Overview 68
- 5.12.1 Dura LLC Pipeline Products & Ongoing Clinical Trials Overview 68
- 5.13 Edwards Lifesciences Corp Company Overview 69
- 5.13.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 69
- 5.14 Foldax Inc Company Overview 76
- 5.14.1 Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview 76
- 5.15 HLT, Inc. Company Overview 79
- 5.15.1 HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
- 5.16 JC Medical, Inc. Company Overview 83
- 5.16.1 JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
- 5.17 JenaValve Technology GmbH Company Overview 88
- 5.17.1 JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 88
- 5.18 Mayo Clinic Company Overview 91
- 5.18.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 91
- 5.19 Medtronic plc Company Overview 92
- 5.19.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 92
- 5.20 Meril Life Sciences Pvt Ltd Company Overview 95
- 5.20.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 95
6 Transcatheter Aortic Valve Implantation (TAVI)- Recent Developments 131
- 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 131
- 6.2 Nov 18, 2019: MyVal transcatheter heart valve reports positive trial results 133
- 6.3 Nov 07, 2019: Edwards Lifesciences gets approval for SAPIEN 3 TAVI valve in Europe 134
- 6.4 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 135
- 6.5 Oct 23, 2019: Edwards Lifesciences reports third quarter results 137
7 Appendix 194
- 7.1 Methodology 194
- 7.2 About GlobalData 197
- 7.3 Contact Us 197
Summary:
Get latest Market Research Reports on Transcatheter Aortic Valves Implantation (TAVI). Industry analysis & Market Report on Transcatheter Aortic Valves Implantation (TAVI) is a syndicated market report, published as Transcatheter Aortic Valves Implantation (TAVI) - Medical Devices Pipeline Assessment, 2019. It is complete Research Study and Industry Analysis of Transcatheter Aortic Valves Implantation (TAVI) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
